I think FDA delay could be to buy some time for th
Post# of 147721
(Total Views: 496)
Posted On: 05/13/2020 10:46:51 AM
I think FDA delay could be to buy some time for the Rendesivir to make money in the market. i am sure Remdesivir can servive till all other player get FDA approve , right now they all in clinical phase1/2/3.
One of the tough competitors for leronlimab is Regeneron's cocktail drug which has IL-6 reducer/ inhibitor
One of the tough competitors for leronlimab is Regeneron's cocktail drug which has IL-6 reducer/ inhibitor
(0)
(0)CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼